Meihua H. Jin

Tianjin Key Laboratory On Technologies Enabling Development Of Clinical Therapeutics And Diagnostics, Key Laboratory Of Immune Microenvironment And Diseases
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells.

LAPTM5-dependent lipophagy enhances ferroptosis sensitivity in glioma cells.

Journal: Translational cancer research

Published: December 05, 2025

Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibition.

Antitumor effect of BC12-3 on multiple myeloma via proteasome inhibition.

Journal: Medical oncology (Northwood, London, England)

Published: February 28, 2025

Lipid metabolism: the potential therapeutic targets in glioblastoma.

Lipid metabolism: the potential therapeutic targets in glioblastoma.

Journal: Cell death discovery

Published: November 05, 2024

Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis.

Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis.

Journal: Biochemical pharmacology

Published: November 01, 2024

Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.

Licochalcone A induces cell cycle arrest and apoptosis via suppressing MAPK signaling pathway and the expression of FBXO5 in lung squamous cell cancer.

Journal: Oncology reports

Published: June 13, 2023

Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC.

Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC.

Journal: Frontiers in pharmacology

Published: April 05, 2023

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer.

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer.

Journal: Frontiers in pharmacology

Published: March 23, 2022

Targeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway.

Targeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway.

Journal: Frontiers in oncology

Published: February 02, 2021

Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo.

Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo.

Journal: Frontiers in cell and developmental biology

Published: January 19, 2021

Suppressive effect of tamarixetin, isolated from Inula japonica, on degranulation and eicosanoid production in bone marrow-derived mast cells.

Suppressive effect of tamarixetin, isolated from Inula japonica, on degranulation and eicosanoid production in bone marrow-derived mast cells.

Journal: Allergologia et immunopathologia

Published: October 20, 2020

STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells.

STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells.

Journal: Cell death & disease

Published: June 29, 2020

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway.

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway.

Journal: Frontiers in pharmacology

Published: February 15, 2020

Showing 1-12 of 46

Last Updated: 09/26/2026